| scholarly article | Q13442814 |
| P50 | author | Lee M. Nadler | Q117474702 |
| P2093 | author name string | S F Schlossman | |
| R Hardy | |||
| J Ritz | |||
| P Stashenko | |||
| J M Pesando | |||
| P2860 | cites work | Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group | Q28296408 |
| Malignant lymphomas: current classification and new observations | Q34049171 | ||
| Combined Studies of Complement Receptor and Surface Immunoglobulin-Bearing Cells and Sheep Erythrocyte Rosette-Forming Cells in Normal and Leukemic Human Lymphocytes | Q34499033 | ||
| Distribution of Ia-like molecules on the surface of normal and leukemic human cells | Q34997756 | ||
| Malignant lymphomas--a conceptual understanding of morphologic diversity. A review | Q36092681 | ||
| A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization | Q36270487 | ||
| Interaction of aggregated -globulin with B lymphocytes | Q36271649 | ||
| Membrane receptor sites for the identification of lymphoreticular cells in benign and malignant conditions | Q36291047 | ||
| Peripheral human T cells sensitized in mixed leukocyte culture synthesize and express Ia-like antigens | Q36342014 | ||
| Ia determinants on human T-cell subsets defined by monoclonal antibody. Activation stimuli required for expression | Q36343167 | ||
| Recognition by pregnancy serums of non-HL-A alloantigens selectively expressed on B lymphocytes | Q36357880 | ||
| Inhibition of antibody-dependent cellular cytotoxicity and immunoglobulin synthesis by an antiserum prepared against a human B-cell Ia-like molecule | Q36359669 | ||
| Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage | Q36360690 | ||
| Subset derivation of T-cell acute lymphoblastic leukemia in man | Q37040358 | ||
| Prognostic significance of lymphocyte surface markers in adult non-Hodgkin's malignant lymphoma | Q39413572 | ||
| Acute lymphoblastic leukemia with pre-B-cell characteristics | Q39664442 | ||
| Pathology of the non-Hodgkin's lymphomas: new classifications | Q39691261 | ||
| Immunologic functions of isolated human lymphocyte subpopulations. V. Isolation and functional analysis of a surface Ig negative, E rosette negative subset | Q39750261 | ||
| The immunological classification of acute lymphoblastic leukemias | Q39770566 | ||
| The T lymphoblastic malignancies | Q40282066 | ||
| The differentiation and function of human T lymphocytes | Q40284222 | ||
| Pre-B-cell leukemia. A new phenotype of childhood lymphoblastic leukemia | Q40672088 | ||
| Clinical Utility of Lymphocyte Surface Markers Combined with the Lukes-Collins Histologic Classification in Adult Lymphoma | Q40716050 | ||
| Antigenic and enzymatic phenotypes of the pre-B subclass of acute lymphoblastic leukaemia | Q40738125 | ||
| Leukemia-associated antigens in ALL | Q41129579 | ||
| A monoclonal antibody defining a lymphoma-associated antigen in man | Q42664567 | ||
| IgG on lymphocyte surfaces; technical problems and the significance of a third cell population | Q43860588 | ||
| Characterization of a human B lymphocyte-specific antigen. | Q44191670 | ||
| Identification by peroxidase staining of monocytes in surface immunofluorescence tests. | Q45269859 | ||
| The IgG receptor: an immunological marker for the characterization of mononuclear cells | Q46936647 | ||
| Surface-bound immunoglobulin as a marker of B lymphocytes in man. | Q47735894 | ||
| Heterogeneity of T-cell lymphoblastic malignancies. | Q53577250 | ||
| B-cell neoplasia in man. | Q53596983 | ||
| Technical aspects of the rosette tests used to detect human complement receptor (B) and sheep erythrocyte-binding (T) lymphocytes | Q54313529 | ||
| A monoclonal antibody to human acute lymphoblastic leukaemia antigen | Q58415273 | ||
| Antisera to acute lymphoblastic leukemia cells | Q66894609 | ||
| Immunologic functions of isolated human lymphocyte subpopulations. VI. Further characterization of the surface Ig negative, E rosette negative (null cell) subset | Q66901427 | ||
| Subpopulations of human T cells identified by receptors for immunoglobulins and mitogen responsiveness | Q67497299 | ||
| Immunoglobulins on the Surface of Neoplastic Lymphocytes | Q69184420 | ||
| A monoclonal antibody reactive with human peripheral blood monocytes | Q72130347 | ||
| Human T lymphocyte surface antigens: partial purification and characterization utilizing a high-titer heteroantiserum | Q72605422 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 134-140 | |
| P577 | publication date | 1981-01-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | A unique cell surface antigen identifying lymphoid malignancies of B cell origin | |
| P478 | volume | 67 |
| Q70249668 | A human B lymphocyte antigen (P-76) shared by B-cell chronic lymphocytic leukemia cells and hairy cell leukemia cells |
| Q50717173 | Adaptive B cell responses in rituximab-treated diffuse large B cell lymphoma patients during complete remission. |
| Q72586552 | Anti-B1 monoclonal antibody and complement treatment in autologous bone-marrow transplantation for relapsed B-cell non-Hodgkin's lymphoma |
| Q38068932 | Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia |
| Q38824182 | Anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia: from uncertainties to promises |
| Q37605247 | Antibody-based therapy of leukaemia |
| Q30275229 | Antibody-siRNA conjugates: drugging the undruggable for anti-leukemic therapy |
| Q39243052 | Antigen Discovery and Therapeutic Targeting in Hematologic Malignancies |
| Q36992671 | B cell origin of non-T cell acute lymphoblastic leukemia. A model for discrete stages of neoplastic and normal pre-B cell differentiation |
| Q37686904 | B-cell monoclonal antibodies and their use in clinical oncology |
| Q38394272 | Biosimilar monoclonal antibodies in lymphoma: a critical appraisal |
| Q33449093 | Bone marrow histopathologic patterns and immunologic phenotype in B-cell chronic lymphocytic leukaemia |
| Q33768464 | CD27-CD70 interactions regulate B-cell activation by T cells |
| Q71815056 | CD27/CD70 interaction directly drives B cell IgG and IgM synthesis |
| Q36589023 | Cancer nanomedicines: so many papers and so few drugs! |
| Q40147232 | Cell lineage in lymphoproliferative disease |
| Q40986836 | Cell surface antigens in leukemias and lymphomas |
| Q35885968 | Centrocytic lymphoma: a distinct clinicopathologic and immunologic entity. A multiparameter study of 18 cases at diagnosis and relapse |
| Q41869246 | Change of CD20 Expression in Diffuse Large B-Cell Lymphoma Treated with Rituximab, an Anti-CD20 Monoclonal Antibody: A Study of the Osaka Lymphoma Study Group |
| Q70218956 | Characterization of interstitial infiltrating cells in Berger's disease |
| Q52831406 | Characterization of new non-T, non-B acute lymphoblastic leukemia cell lines: Analysis of surface antigens by quantitative cellular radioimmunoassay and flow cytometry |
| Q72542248 | Clinical usefulness of monoclonal-antibody phenotyping in childhood acute lymphoblastic leukemia |
| Q70992242 | Construction of an antigenic map for human B-cell precursors |
| Q90734654 | Current Advances in Immunotherapy for Acute Leukemia: An Overview of Antibody, Chimeric Antigen Receptor, Immune Checkpoint, and Natural Killer |
| Q33645994 | Cytological and immunohistochemical study of the limbal form of vernal keratoconjunctivitis by the replica technique |
| Q38757530 | Defective quorum sensing of acute lymphoblastic leukemic cells: evidence of collective behavior of leukemic populations as semi-autonomous aberrant ecosystems |
| Q38896113 | Development of Novel Anti-Cd20 Monoclonal Antibodies and Modulation in Cd20 Levels on Cell Surface: Looking to Improve Immunotherapy Response |
| Q36490753 | Development of antibodies and chimeric molecules for cancer immunotherapy |
| Q46176587 | Developmental Immunotoxicology Assessment of Rituximab in Cynomolgus Monkeys |
| Q40831574 | Developments in purging in autotransplantation. |
| Q40926746 | Different stages of B cell differentiation in non-T acute lymphoblastic leukemia |
| Q48192887 | Emerging role of immunotherapy in precursor B-cell acute lymphoblastic leukemia |
| Q47820029 | Engineering therapeutic monoclonal antibodies |
| Q34336342 | Enhanced anti-tumor activity of the glycoengineered type II CD20 antibody obinutuzumab (GA101) in combination with chemotherapy in xenograft models of human lymphoma |
| Q36348358 | Epstein-Barr virus susceptibility of normal human B lymphocyte populations |
| Q35982370 | Establishment and characterisation of an Epstein-Barr virus negative B immunoblastic lymphoma cell line |
| Q33822136 | Evidence for genetic restriction in the suppression of erythropoiesis by a unique subset of T lymphocytes in man. |
| Q54595322 | Expression of CD11a (LFA-1) on B-chronic Lymphocytic Leukemia and Lymphoma Cells: Correlation with Cell Surface Immunoglobulin Intensity and CD58 (LFA-3) Expression. |
| Q35386633 | Expression of cell surface markers after human B lymphocyte activation |
| Q38758789 | Feasibility and Safety of RNA-transfected CD20-specific Chimeric Antigen Receptor T Cells in Dogs with Spontaneous B Cell Lymphoma. |
| Q37831958 | Flow cytometry and its use in the diagnosis and management of mature lymphoid malignancies |
| Q68817092 | Follicular mantle zone cell subpopulations detected by monoclonal antibody SN3 |
| Q34535750 | Functional and phenotypic studies of Japanese adult T cell leukemia cells |
| Q35880618 | Haematological malignancies: at the forefront of immunotherapeutic innovation |
| Q40054666 | High CD21 expression inhibits internalization of anti-CD19 antibodies and cytotoxicity of an anti-CD19-drug conjugate. |
| Q36280836 | Human prostate specific and shared differentiation antigens defined by monoclonal antibodies |
| Q48350859 | Humanization and characterization of the anti-HLA-DR antibody 1D10. |
| Q36232675 | Humoral immunity in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis |
| Q42753099 | Immature sinus histiocytosis. Light- and electron-microscopic features, immunologic phenotype, and relationship with marginal zone lymphocytes |
| Q33647035 | Immune cells in a case of postherpetic marginal trophic ulcer |
| Q45958464 | Immunoarchitecture of the "pseudofollicles" of well-differentiated (small) lymphocytic lymphoma: a comparison with true follicles. |
| Q68502385 | Immunobiology of chronic lymphocytic leukemia |
| Q41447510 | Immunocytological study of phlyctenular eye disease |
| Q33838760 | Immunoglobulin gene rearrangement and antigenic profile confirm B cell origin of primary cerebral lymphoma and indicate a mature phenotype. |
| Q34608676 | Immunoglobulin mu-chain gene rearrangement in a patient with T cell acute lymphoblastic leukemia |
| Q44854514 | Immunohistological diagnosis of primary brain lymphoma using monoclonal antibodies: confirmation of B-cell origin. |
| Q68309185 | Immunophenotypic differences between plasmacytoma/multiple myeloma and immunoblastic lymphoma |
| Q69980109 | Immunotopographic assessment of lymphoid and plasma cell malignancies in the bone marrow |
| Q33866024 | Impact of rituximab-associated B-cell defects on West Nile virus meningoencephalitis in solid organ transplant recipients |
| Q37016392 | Induction of human B cell antigens in non-T cell acute lymphoblastic leukemia |
| Q58205117 | Induction of suppression following autologous mixed lymphocyte reaction; role of a novel 2H4 antigen |
| Q37025883 | Induction therapy in renal transplantation : an overview of current developments |
| Q69986623 | Influence of pre-incubation with one antibody on the binding of a second by human lymphocytes |
| Q70270358 | Isolation and characterization of human B lymphocyte enriched populations. I. Purification of B cells by immune rosette depletion |
| Q70290861 | Isolation of Cultured Human Monocytes/Macrophages in Suspension Utilizing Liquid and Solid Phase Gelatin |
| Q68821323 | Leukocyte analysis using monoclonal antibodies in human glomerulonephritis |
| Q46191765 | Localization of collagenase mRNA in rheumatoid arthritis synovium by in situ hybridization histochemistry |
| Q47198384 | Long-term safety of rituximab induced peripheral B-cell depletion in autoimmune neurological diseases |
| Q69058851 | Lymph node architecture in Hodgkin's disease: evidence for the role of the composite nodule in nodular sclerosing Hodgkin's disease |
| Q35835299 | Lymphocyte compartments in human spleen. An immunohistologic study in normal spleens and uninvolved spleens in Hodgkin's disease |
| Q40131718 | Lymphocyte receptors |
| Q42374173 | Lymphocytic lymphoma/B-chronic lymphocytic leukaemia--an immunohistopathological study of peripheral B lymphocyte neoplasia |
| Q70275218 | Lymphoproliferative diseases in Japan and Western countries: Proceedings of the United States—Japan seminar, September 6 and 7, 1982, in Seattle, Washington |
| Q37448352 | Molecular mechanisms of resistance to Rituximab and pharmacologic strategies for its circumvention |
| Q72742884 | Monoclonal Antibodies Directed Against Human Lymphoid, Monocytic, and Granulocytic Cells: Reactivities with Other Tissues |
| Q58415195 | Monoclonal Antibody-Purged Bone Marrow Transplantation Therapy for Multiple Myeloma |
| Q34700655 | Monoclonal antibodies for non-Hodgkin's lymphoma: state of the art and perspectives |
| Q40155227 | Monoclonal antibodies in clinical medicine--a review |
| Q26826880 | Monoclonal antibody therapy and renal transplantation: focus on adverse effects |
| Q35611416 | Multimodality imaging of coiled-coil mediated self-assembly in a "drug-free" therapeutic system |
| Q40212430 | Multiple myeloma, Waldenström's macroglobulinemia, and benign monoclonal gammopathy: characteristics of the B cell clone, immunoregulatory cell populations and clinical implications. |
| Q44652739 | Neoplastic B cells with cerebriform nuclei in follicular lymphomas |
| Q37222783 | New insights into the mechanisms of action of radioimmunotherapy in lymphoma. |
| Q70314954 | New perspectives in immunodermatopathology |
| Q39441297 | Novel Insights into Membrane Targeting of B Cell Lymphoma. |
| Q35858079 | Phenotypic expression of B-lymphocytes. 1. Identification with monoclonal antibodies in normal lymphoid tissues |
| Q38157384 | Potential applications of monoclonal antibodies in cancer diagnosis and therapy |
| Q40263609 | Pre-B cells; normal and abnormal development |
| Q36347276 | Purification and characterization of fetal hematopoietic cells that express the common acute lymphoblastic leukemia antigen (CALLA). |
| Q35206373 | Radioimmunotherapy for non-Hodgkin's lymphoma |
| Q53059480 | Rapid response to and long-term effectiveness of anti-CD20 antibody in conventional therapy resistant Graves' orbitopathy: A five-year follow-up study. |
| Q42076420 | Real time analysis of binding between Rituximab (anti-CD20 antibody) and B lymphoma cells |
| Q37343305 | Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia |
| Q39595325 | Regulation of human B lymphocyte activation, proliferation, and differentiation |
| Q33706729 | Rituximab |
| Q36752014 | Rituximab and its role as maintenance therapy in non-Hodgkin lymphoma |
| Q37879578 | Rituximab and minimal change nephrotic syndrome: a therapeutic option |
| Q37937704 | Rituximab as first-line maintenance therapy following rituximab-containing therapy for follicular lymphoma: profile report |
| Q41241909 | Rituximab for the treatment of patients with chronic lymphocytic leukemia |
| Q92281461 | Rituximab in the treatment of immune thrombocytopenia: what is the role of this agent in 2019? |
| Q44161639 | Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia |
| Q34186569 | Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia |
| Q37875060 | Rituximab: as first-line maintenance therapy following rituximab-containing therapy for follicular lymphoma |
| Q34733916 | Rituximab: review and clinical applications focusing on non-Hodgkin's lymphoma |
| Q70055690 | Role of the 2H4 molecule in the activation of suppressor inducer function |
| Q35835286 | SIg-E- ("null-cell") non-Hodgkin's lymphomas. Multiparametric determination of their B- or T-cell lineage |
| Q38151570 | Somatic alterations as the basis for resistance to targeted therapies |
| Q36345615 | Stages of B cell differentiation in human lymphoid tissue |
| Q38655812 | Structure, function, and genetics of human B cell-associated surface molecules |
| Q59095281 | Suppression of the normal mouse c-myc oncogene in human lymphoma cells |
| Q52833968 | Synthesis of Kappa Light Chains by Cell Lines Containing an 8;22 Chromosomal Translocation Derived from a Male Homosexual with Burkitt's Lymphoma |
| Q70992237 | Sézary cells with an unusual phenotype, their modulation with 12-O-tetradecanoyl phorbol-13-acetate (TPA) in vitro, and their relationship to T-cell development |
| Q70999124 | TPA (12-O-tetradecanoyl-phorbol-13-acetate) activation and differentiation of human peripheral B lymphocytes |
| Q42077750 | Targeted alpha-therapy using [Bi-213]anti-CD20 as novel treatment option for radio- and chemoresistant non-Hodgkin lymphoma cells |
| Q40108222 | Targeting to lymphoid cells of the immune network |
| Q45236637 | The B-cells that express anti-MAG antibodies in neuropathy and non-malignant IgM monoclonal gammopathy belong to the CD5 subpopulation |
| Q68957610 | The cellular basis for the induction of antigen-specific T8 suppressor cells |
| Q70304119 | The cellular composition of granulomas in mesenteric lymph nodes from patients with Crohn's disease |
| Q35835722 | The composite nodule. A structural and functional unit of the reactive human lymph node |
| Q40246666 | The contribution of immunologic methods to the classification of leukemias and malignant lymphomas. |
| Q37689179 | The role of B cell depleting therapy in graft versus host disease after allogeneic hematopoietic cell transplant |
| Q43808135 | The role of monoclonal antibodies in brain tumour diagnosis and cerebrospinal fluid (CSF) cytology |
| Q42372842 | Therapeutic Antibodies: What Have We Learnt from Targeting CD20 and Where Are We Going? |
| Q37633537 | Therapeutic agents for patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor-alpha antagonists |
| Q55245455 | Thymoma: lymphoid and epithelial components mirror the phenotype of normal thymus. |
| Q37111904 | Treating multiple sclerosis with monoclonal antibodies |
| Q24683318 | Ultrastructural studies of human lymphoid cells. mu and J chain expression as a function of B cell differentiation |
| Q40162882 | Use of monoclonal antibodies in autologous and allogeneic bone marrow transplantation |
| Q40053831 | Use of rituximab in multiple sclerosis: current progress and future perspectives |
Search more.